CONFERENCE COVERAGE SERIES
Gladstone/DZNE Workshop: From Science to Therapeutics: The Best Way Forward, 2013
The Gladstone Institutes, San Francisco, CA, U.S.A.
15 – 17 April 2013
The small scientific workshop From Science to Therapeutics: The Best Way Forward drew 150 researchers to San Francisco 15-17 April 2013, and united a hodgepodge of topics under the theme of how to move scientific discoveries from the lab bench to the clinic. Multifactorial diseases such as AD likely "cannot be conquered by a single approach or drug," said Lennart Mucke of the Gladstone Institute of Neurological Disease, San Francisco, who co-organized the meeting with Pierluigi Nicotera of the German Center for Neurodegenerative Disease. Over the coming days, read Esther Landhuis' highlights, which cover new functions for BACE, novel therapeutic approaches centered around ubiquitination, acetylation, stress response pathways, and a longevity gene. [Image courtesy of Lennart Mucke.]
Therapeutic Approaches Target Deubiquitinase, Protein Turnover
This scientific meeting that drew some 150 researchers to San Francisco 15-17 April 2013 featured an unusually broad array of topics...
Paracrine Signal From BACE1-Clipped Neuregulin Rescues Myelin
As β-secretase inhibitors head into Alzheimer’s disease trials, researchers are paying close attention to what else BACE1 does besides snip amyloid-β from APP...
Could Longevity Factor, Epilepsy Med, Treat AD One Day?
At a San Francisco conference addressing Alzheimer’s and related disorders, the agenda featured a diverse mix of topics—occasionally even from the same lab...